wersja polska  
Mediton - Publishing House
Start page  Journals  Books  Conferences  News  Mediton  Contact   
print this
   Allergy Asthma Immunology - archive  

Allergy Asthma Immunology
     Editorial staff
     Editorial board
     For authors
Allergology Review

 Search in articles:
  Authority of Polish Society of Allergology

vol 18. no 2. June 2013  

 Review articles
Biological treatment of severe/difficult asthma
Mateusz Łukaszyk, Ewelina Jastrzębska, Ziemowit Ziętkowski, Anna Bodzenta-Łukaszyk

Asthma is a chronic inflammatory disease of the airways. Nearly 60% of asthma cases have allergic background. About 5-10% of patients treated for asthma do not respond well to standard treatment suggested by GINA 2006 guidelines. The article reviews the anti-IgE therapy for patients with severe/difficult asthma as well as points out the prospects of treatment with new biological drugs now being in 2nd and 3rd phase of clinical trials, which may play a significant role in severe asthma treatment in the near future.

keywords: astma ciężka/ trudna, omalizumab, mepolizumab,lebrikizumab, severe/difficult asthma, omalizumab, mepolizumab,lebrikizumab

pages: from 86 to 90

estimated time of download (248 kB)
broadband speed:561282565121024[kbps]

You need to have Adobe Acrobat Reader to view the PDF file. It's free. If you don't have the Adobe Acrobat Reader plugin yet, you can get it HERE.

Start page | Journals | Books | Conferences | News | Mediton | Contact

Copyright © 1996-2020 Mediton Publishing House | All rights reserved.